News
Why Viatris Stock Is Jumping Today
Shares of Viatris (NASDAQ: VTRS) were jumping 6% higher as of 11:18 a.m. ET on Thursday after rising as much as 12.4% earlier in the day. The solid gain came after the global healthcare company
Should Pfizer's Strong Quarter Calm Investor Concerns About the Stock?
Demand for COVID-19 vaccines and drugs has been fading for a while now. And that has put a big dent in Pfizer's (NYSE: PFE) sales and profit numbers. On top of that, the stock is also facing
2 Dividend Stocks to Double Up on Right Now
When the stock market gets choppy, it can be nice to have extra cash regularly deposited in your account. Let's look at two top stocks that pay regular dividends to shareholders. These profitable
Here's Why Eli Lilly Stock Dropped 12% Last Month
Shares of Eli Lilly (NYSE: LLY) fell 20% in July, according to data from S&P Global Market Intelligence. The pharmaceutical stock tumbled after one of the company's competitors announced promising
Sarepta Therapeutics (SRPT) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Sarepta Therapeutics (NASDAQ: SRPT)Q2 2024 Earnings CallAug 07, 2024, 4:30 p.m. ET
Operator
Source Fool.com
EQS-News: Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb
MannKind (MNKD) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
MannKind (NASDAQ: MNKD)Q2 2024 Earnings CallAug 07, 2024, 9:00 a.m. ET
Operator
Source Fool.com
Why Latham Group Stock Is Making a Splash Today
Swimming pool manufacturer Latham Group (NASDAQ: SWIM) rode a wave of cost cuts to better-than-expected earnings. Investors are diving in, sending Latham shares up 42% as of 2:30 p.m. ET.
Latham
Why Amgen Stock Is Down Today Despite Solid Q2 Results
By no means were Amgen's (NASDAQ: AMGN) second-quarter numbers "bad." Revenue for most of its core drugs was up year over year, and the slight earnings dip is the predictable result of rising
Here's My Top AI Stock to Buy in August
Let's be honest. After the stunning launch of OpenAI's ChatGPT in late 2022, the generative artificial intelligence (AI) industry has been more hype than substance. While hardware makers like Nvidia
3 Dividend Growth Stocks to Buy Hand Over Fist in August
Dividend growth investing is an excellent strategy for any long-term investor. It involves buying and holding companies that pay and raise their dividends year after year. Investors benefit from
EQS-News: Evotec SE reports first half-year 2024 results on 14 August 2024
Exelixis (EXEL) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Exelixis (NASDAQ: EXEL)Q2 2024 Earnings CallAug 06, 2024, 5:00 p.m. ET
Operator
Source Fool.com
Dynavax Technologies (DVAX) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Dynavax Technologies (NASDAQ: DVAX)Q2 2024 Earnings CallAug 06, 2024, 4:30 p.m. ET
Operator
Source Fool.com
Karyopharm Therapeutics (KPTI) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Karyopharm Therapeutics (NASDAQ: KPTI)Q2 2024 Earnings CallAug 06, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Zoetis (ZTS) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Zoetis (NYSE: ZTS)Q2 2024 Earnings CallAug 06, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Why Zoetis Stock Was Moving Higher Tuesday
Shares of Zoetis (NYSE: ZTS), the leading animal pharmaceutical maker, were climbing today after the company reported better-than-expected results in its second-quarter earnings report and raised
3 Unstoppable Dividend Stocks Yielding More Than 4% for Income-Seeking Investors to Buy in August and Hold Forever
The past week has been a rotten one for most portfolios. On Monday, Aug. 5, the benchmark S&P 500 index began the trading session about 3% lower. That led the benchmark index to a loss of about 9.4%
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Except for the last several days, the past 12 months have been pretty good for stocks across the board and especially successful for Vertex Pharmaceuticals (NASDAQ: VRTX). Shares of the biotech
EQS-News: Biotest increases sales in the first half of 2024 by 35% to Euro 372 million
Axsome Therapeutics (AXSM) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Axsome Therapeutics (NASDAQ: AXSM)Q2 2024 Earnings CallAug 05, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Why Axsome Therapeutics Stock Is Sinking Today
Shares of Axsome Therapeutics (NASDAQ: AXSM) were sinking 7.5% as of 11:24 a.m. ET on Monday. And while many stocks were tumbling due to the Bank of Japan's interest rate hike, that wasn't the main
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
When it comes to investing in the right companies for your portfolio, you need to ensure you select businesses that you understand and have the competitive advantages, financials, and leadership to